Coverage
-
May 13, 2020
Illumina Inc. and Natera Inc. have agreed to drop dueling patent infringement claims over fetal DNA testing technology in California federal court and to firm up a licensing agreement, according to a newly submitted regulatory filing.
2 other articles on this case.
View all »